ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 177 filers reported holding ACCELERON PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,875,000 | -44.7% | 47,453 | -42.5% | 4.02% | +119.0% |
Q2 2019 | $3,388,000 | +141.5% | 82,473 | +173.8% | 1.84% | -21.7% |
Q1 2019 | $1,403,000 | +73.6% | 30,125 | +62.3% | 2.34% | +5.0% |
Q4 2018 | $808,000 | -64.6% | 18,564 | -53.5% | 2.23% | +5.8% |
Q3 2018 | $2,284,000 | +108.6% | 39,912 | +76.9% | 2.11% | +95.9% |
Q2 2018 | $1,095,000 | – | 22,558 | – | 1.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 2 | $0 | 0.00% |